Page last updated: 2024-10-23

aztreonam and Leukemia, Myeloid

aztreonam has been researched along with Leukemia, Myeloid in 2 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mazzariol, A1
Zuliani, J1
Fontana, R1
Cornaglia, G1
García Sánchez, JE1
Vazquez López, ML1
Blazquez de Castro, AM1
Perez Simon, JA1
Gutierrez, NG1
Martin, IT1
García-Rodríguez, JA1

Other Studies

2 other studies available for aztreonam and Leukemia, Myeloid

ArticleYear
Isolation from blood culture of a Leclercia adecarboxylata strain producing an SHV-12 extended-spectrum beta-lactamase.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:4

    Topics: Acute Disease; Anti-Bacterial Agents; Aztreonam; Bacteremia; beta-Lactam Resistance; beta-Lactamases

2003
Aztreonam/clavulanic acid in the treatment of serious infections caused by Stenotrophomonas maltophilia in neutropenic patients: case reports.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:3

    Topics: Adult; Aged; Aztreonam; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Multiple; Drug Therapy,

1997